Skip to main content
. 2007 Jun;148(3):537–545. doi: 10.1111/j.1365-2249.2007.03371.x

Fig. 6.

Fig. 6

Interleukin (IL)-2 elicited from positively selected CD4+ lung lymphocytes stimulated in vitro with anti-CD3 and anti-CD28 antibodies, without (hatched bars) and with recombinant murine TGF-β soluble receptor II (TGFβsrII) added to the wells at 5 µg/ml (black bars). There is an insignificant increase in elicited IL-2 with TGFβsrII at the day 21 time-point only (P = 0·25 stimulated (STIM) versus TGFβsrII), and no evident augmentation at days 28 and 35 post-infection.